MedTekon 2025, the flagship event of the Medical Technology Association of India (MTaI), recently convened policymakers, global dignitaries, investors, and healthcare leaders at Taj Palace, New Delhi.
Focused on Investments, Reforms, and Synergies, the event set the agenda for policy acceleration, investment growth, and technological advancements in India’s MedTech sector.
The event was graced by Chief Guest MAnupriya Patel, Union Minister of State for Health & Family Welfare and Chemicals & Fertilizers, and Guest of Honour Dr V. K. Paul, Member, NITI Aayog, who underscored the critical role of medical technology in shaping India’s healthcare future.
While addressing the gathering, Anupriya Patel said, “It is an honour to inaugurate MedTekon 2025, a key platform uniting industry leaders, policymakers, and healthcare stakeholders to shape the future of India’s MedTech sector. With the industry poised to double its market size to $30 billion by 2030 and expand its global share from 1.65% to 10-12%, India is rapidly emerging as a MedTech powerhouse. Our exports reached $3.8 billion last year, reflecting the sector’s growing manufacturing strength and global competitiveness. As we drive this momentum forward, collaborative efforts in innovation, investment, and policy reforms will be crucial to positioning India as a leader in affordable, high-quality medical technology.”
In his remarks during the session on Catalysing Foreign & Domestic Investments in MedTech, Dr. V. K. Paul, Member, Niti Aayog said, “India’s 4,000+ health-tech startups need greater investment, regulatory support, and structured incubation to scale globally. Additionally, harmonising regulatory standards with global benchmarks is vital for investor confidence and sector growth. By focusing on innovation, investment, and policy stability, we can cement India’s role as a leader in affordable, high-quality medical technology."
Pavan Choudary, Chairman, MTaI, emphasised the need for investment-friendly policies, regulatory coherence, and a robust MedTech infrastructure to support India’s growing healthcare needs.
ble for de-humanization and a lot of stress, Mr. Choudary disagreed and highlighted, “The rise of communities like Hikikomori (term used in Japan) for those who prefer technology-driven interactions over human engagement as human interactions can lead to some level of stress and distress. Machines don’t judge and don’t tire and therefore are preferred by the many millions of hikikomories in the world today, whose number is soaring.”
A major focus area during the event was catalysing foreign and domestic investments, where stakeholders explored India’s potential as a global MedTech manufacturing and R&D hub. In the discussion on hospital technology integration, experts delved into the impact of AI, robotics, and digital health solutions on improving patient outcomes.
Another key session on reimbursement policies examined the case to design health insurance for emerging needs. The regulatory panel addressed harmonising standards, reducing non-tariff barriers, and other aspects regarding regulatory and ease of doing business. The final session highlighted ethical marketing practices in MedTech and the need for skill development programmes to create a future-ready workforce capable of leveraging next-generation medical innovations.
